![]() |
||||||||
|
Drug Facts |
|
||||||||||||||||||||||||||||||||||||||||||
|
Benzodiazepines
SOURCE: Benzodiazepines are widely prescribed as sedatives, to combat anxiety, as skeletal muscle relaxants, anti-epileptics and anti-convulsants. However, some benzodiazepines leak onto the street, and are quite widely misused. More recently, benzodiazepines, especially diazepam, have been illicitly imported in to the UK. Some have been entering from Eastern Europe and sold on the illicit markets. Others have been ordered on-line from one of the many Internet Pharmacies. Some of these tablets are fake, or or variable quality. However, these imported tablets have meant that benzodiazepines remain widely used and available, even though the number of prescribed drugs has decreased in recent years. The most frequently available
drugs are those with italicised slang names above. Valium, Temazepam
and Rohypnol are the most commonly available on the illicit market. APPEARANCE: The appearance of each drug varies widely from drug-company to drug-company. Most come as tablets, in a variety of shapes, colours and strengths. A few also come in preparations for injection, such as Valium ampoules, which command a higher street value. The main-stay of the UK benzodiazepine market is diazepam (Valium). These are typically 5mg or 10mg tablets: 10mg tablets are generally blue, the 5mg tablets are white or yellow, though this is not always the case. Temazepam often comes in small egg-shaped caplets, or as tablets. COST: At a street level, benzodiazepines have a very low value, typically around 50p per tablet. Ampoules can cost a pound or two. QUALITY: Assuming that the pills are correctly identified and genuine, quality is assured. However, it is difficult to correctly identify all of the drugs in this family by eye, let alone assay the strength, so mistakes in strength and name are frequent amongst those purchasing outside medical spheres. Some illicitly produced, imported benzodiazepines are of variable strength. METHODS OF USE: Tablets are designed for oral use, though some users crush and inject tablets. EFFECTS: They induce physical relaxation, and reduce stress and anxiety. Drowsiness and sleepiness are often present. In addition, they may cause forgetfulness, slurred speech, clumsiness and confusion. Some users experience depression and, paradoxically, a few users become over-excited or violent. Some users gain a feeling of invulnerability or invisibility when using benzodiazepines. Some people find this useful when, for example, shoplifting. HEALTH IMPLICATIONS: When used within a supervised medical regime, benzodiazepines should not be used for extensive periods as tolerance develops rapidly and withdrawal can be an unpleasant and, in some cases, dangerous process. After a few weeks, and certainly within a few months, they cease to be effective at promoting sleep and subsequently cease to be effective in reducing anxiety. Indeed, the converse becomes true; without increasing the dose, a user is liable to experience insomnia, anxiety, tremors and, in severe cases convulsions. Current prescribing practice is to prescribe at the lowest doses possible for the shortest period possible, and discouraging long-term prescribing. People who have been on long-term prescriptions should be having their prescriptions reviewed and, where feasible, reduced. Withdrawal from Benzodiazepines, especially when they have been used for more than a month, should only be done under medical supervision. IT IS POSSIBLE TO DIE DUE TO SEVERE BENZODIAZEPINE WITHDRAWAL. There is a low risk of
fatal overdose; this risk is raised through ignorance as to the strength
of various tablets. Risks are exacerbated when benzodiazepines are
combined with other depressant drugs such as alcohol or heroin. The
presence of benzodiazepines is a significant factor in opiate-induced
overdoses. LEGAL STATUS: Benzodiazepines are Class C drugs. Most of them are Schedule 4i drugs, meaning that they can only be supplied and produced by those authorised to do so. Since February 2002 it has been an offence to possess Schedule 4i drugs without prescription. Temazepam and Rohypnol, are Schedule 3 drugs; it is also an offence to possess these without authorization, such as a prescription. OTHER INFORMATION: Benzodiazepines were introduced and have largely supplanted the BARBITURATE group of drugs, which were widely prescribed and widely misused in the seventies. They were seen as preferential to barbiturates as the risks of overdose, dependence and side-effects were thought to be less. They are very widely prescribed; some critics argue that they are over-prescribed, and do not tackle the causes, merely masking symptoms temporarily. They are used recreationally in a number of settings. Some people combine benzodiazepines with alcohol to enhance and increase intoxication. Some stimulant users take benzodiazepines to alleviate the "come-down" from speed, Ecstasy or cocaine, and to promote sleep. It is not uncommon for dependent heroin users to use benzodiazepines when heroin is unavailable, or to use them to help offset some of the symptoms of withdrawal. The use of benzos on top of prescribed opiates - such as with methadone or subutex - is also common as it can make the effects of the opiates feel stronger. Such use increases risk of overdose. A few people self-medicate with benzodiazepines to alleviate mental discomfort caused by mental health problems, painful memories, or to escape unpleasant circumstances. For such users, where unsupervised use may be long-term and extensive, careful assessment of needs, of underlying reason for the drug use, and comprehensive care plans are likely to be needed to achieve reduction and cessation of drug use. The increased availability of Benzos in the UK, thanks to the Internet and other illicit routes, has meant that the level and extent of benzo use has probably increased lately. Workers have reported people entering treatment with staggeringly high levels of benzodiazepine dependency, built up exlcusively using street benzos. |
|||||||||||||||||||||||||||||||||||||||||||
|
Drug Briefings: |
|||||||||||||||||||||||||||||||||||||||||||
| Drug Class and Schedule | |||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
| @nticopyright KFx: redistribution on a not-for-profit basis: credit and link back to KFx site required: updated July 2007 | |||||||||||||||||||||||||||||||||||||||||||